Á¦2ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ&´ëÇÑ°£ÇÐȸ ÇÕµ¿½ÉÆ÷Áö¿ò : 2024-01-27
±³À°ÀÏÀÚ : 2024-01-27
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯ ¿¬±¸È¦
±³À°ÁÖÁ¦ : Á¦2ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ&´ëÇÑ°£ÇÐȸ ÇÕµ¿½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇÑÃé´ãµµÇÐȸ
´ã´çÀÚ : ¼ÛÀç¼ø
¿¬¶ôó : 02-2285-5145
À̸ÞÀÏ : kpba@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í »çÀüµî·Ï ¹«·á, ÇöÀåµî·Ï 10,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 13:30~13:50 Introduction to EUS-based endohepatology ÀÌÀç¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 13:50~14:10 Current situation and clinical application of interventional endoscopy Á¶ÀçÈñ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 14:10~14:30 Clinical applications of contrast-enhanced ultrasound for focal liver lesions ÀÌÇö¿õ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 14:30~14:50 Indications and challenges of transarterial radioembolization in hepatocellular carcinoma ÀÌÀ±ºó(¼¿ïÀÇ´ë)
Åä·Ð 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 14:50~15:00 Discussion ( )
ÈÞ½Ä 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 15:00~15:20 Break ( )
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 15:20~15:40 ASH vs. MASH (NASH): pathomechanisms and therapeutic targets ¼®±âÅÂ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 15:40~16:00 Pathogenesis, mechanisms, research and future directions in alcoholic pancreatitis Á¶ÁßÇö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 16:00~16:20 Update on current and emerging strategies for the management of severe alcoholic hepatitis Á¤½Â¿ø(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 16:20~16:40 Management of alcoholic pancreatitis Á¤¹Î±Ô(°æºÏÀÇ´ë)
Åä·Ð 01¿ù 27ÀÏ ¼¿ï´ëº´¿ø CMI ¼¼ºÈ¯ ¿¬±¸È¦ 16:40~16:50 Discussion ( )